These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7536601)
61. A reappraisal of the significance of thymic germinal centers in myasthenia gravis. Leong AS; Vignaendra V; Ghee LT Eur Neurol; 1976; 14(1):53-9. PubMed ID: 1253802 [TBL] [Abstract][Full Text] [Related]
62. Immunohistochemical and enzyme histochemical contributions to the problem concerning the role of the thymus in the pathogenesis of myasthenia gravis. Palestro G; Tridente G; Botto Micca F; Novero D; Valente G; Godio L Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(2):173-86. PubMed ID: 6139909 [TBL] [Abstract][Full Text] [Related]
63. The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases. Berrih-Aknin S; Morel E; Raimond F; Safar D; Gaud C; Binet JP; Levasseur P; Bach JF Ann N Y Acad Sci; 1987; 505():50-70. PubMed ID: 3318621 [No Abstract] [Full Text] [Related]
64. [Myasthenia gravis: epithelial cells of the hyperplastic thymus. Morphometric and ultrastructural study]. Répássy G; Szobor A; Lapis K; Szathmáry I Morphol Igazsagugyi Orv Sz; 1979 Jul; 19(3):199-204. PubMed ID: 503091 [TBL] [Abstract][Full Text] [Related]
65. Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma. Fujii Y; Hayakawa M; Nakahara K J Neurol; 1992 Feb; 239(2):82-8. PubMed ID: 1552308 [TBL] [Abstract][Full Text] [Related]
66. Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravis. Hu B; Simon-Keller K; Küffer S; Ströbel P; Braun T; Marx A; Porubsky S Exp Neurol; 2016 Mar; 277():76-85. PubMed ID: 26708556 [TBL] [Abstract][Full Text] [Related]
67. Thymus involvement in early-onset myasthenia gravis. Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185 [TBL] [Abstract][Full Text] [Related]
68. The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ. Weiss JM; Cufi P; Le Panse R; Berrih-Aknin S Rev Neurol (Paris); 2013; 169(8-9):640-9. PubMed ID: 24008049 [TBL] [Abstract][Full Text] [Related]
69. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice. Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242 [TBL] [Abstract][Full Text] [Related]
70. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown. Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666 [TBL] [Abstract][Full Text] [Related]
71. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma. Ichikawa Y; Shimizu H; Yoshida M; Arimori S Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261 [TBL] [Abstract][Full Text] [Related]
72. B cells in thymomas. Kornstein MJ; Kay S Mod Pathol; 1990 Jan; 3(1):61-3. PubMed ID: 2408037 [TBL] [Abstract][Full Text] [Related]
73. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis. Namba T; Nakata Y; Grob D Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115 [TBL] [Abstract][Full Text] [Related]
74. Approaches for studying the pathogenic T cells in autoimmune patients. Willcox N; Baggi F; Batocchi AP; Beeson D; Harcourt G; Hawke S; Jacobson L; Matsuo H; Moody AM; Nagvekar N Ann N Y Acad Sci; 1993 Jun; 681():219-37. PubMed ID: 8357164 [TBL] [Abstract][Full Text] [Related]
75. Are linear AChR epitopes the real culprit in ocular myasthenia gravis? Wu X; Tüzün E Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692 [TBL] [Abstract][Full Text] [Related]
76. Antibody heterogeneity and specificity in myasthenia gravis. Vincent A; Whiting PJ; Schluep M; Heidenreich F; Lang B; Roberts A; Willcox N; Newsom-Davis J Ann N Y Acad Sci; 1987; 505():106-20. PubMed ID: 2446546 [TBL] [Abstract][Full Text] [Related]
77. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes. Link H; Xu ZY; Melms A; Kalbacher H; Sun JB; Wang ZY; Fredrikson S; Olsson T Scand J Immunol; 1992 Sep; 36(3):405-14. PubMed ID: 1381518 [TBL] [Abstract][Full Text] [Related]
78. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis. Shirai T; Miyata M; Nakase A; Itoh T Clin Exp Immunol; 1976 Oct; 26(1):118-23. PubMed ID: 1087211 [TBL] [Abstract][Full Text] [Related]
79. Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis and thymic epithelial tumors. Marx A; Schömig D; Schultz A; Gattenlöhner S; Jung A; Kirchner T; Melms A; Müller-Hermelink HK Thymus; 1994; 23(2):83-93. PubMed ID: 7725387 [TBL] [Abstract][Full Text] [Related]
80. In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions. Safar D; Berrih-Aknin S; Morel E J Clin Immunol; 1987 May; 7(3):225-34. PubMed ID: 3496354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]